- Home
- Applications
- asia middle east
- disease patients
Show results for
Refine by
Disease Patients Product Applications In Asia Middle East
5 applications found
Shifting from Crisis Management to Health Maintenance. With an unparalleled approach, Vectorious’ V-LAP platform is emerging as the treatment choice for heart failure ...
ByVectorious based in Tel Aviv, ISRAEL
The endocrine and metabolic system includes endocrine glands and endocrine tissues, which regulate human function by secreting hormones. Endocrine diseases are rare and often very difficult to diagnose and treat. Among the 121 rare diseases included on China’s national list of rare diseases in 2018, more than 20 are endocrine/metabolic-related rare ...
ByRareStone Group based in Shanghai, CHINA
Rare neurological diseases include developmental defects of the nervous system, genetic and metabolic diseases, neuroimmune diseases, neurological tumors, special types of infectious diseases of the nervous system, neurodegenerative diseases, and neuromuscular diseases. At present, more than 7,000 rare diseases have been found in humans, about 60% of which are neurological ...
ByRareStone Group based in Shanghai, CHINA
Alzheimer’s disease is a major cause of severe cognitive decline in the aged. The primary cognitive deficiencies are revealed in working memory, language, executive functions, attention, and long-term ...
ByBrainsWay Ltd. based in Burlington, MASSACHUSETTS (USA)
Our First DCGI Approved Stem Cell Product: Stempeucel® is the FIRST innovative stem cell based biological product to be approved by DCGI (Indian FDA) for manufacturing and marketing for the treatment of Critical Limb Ischemia (CLI). Stempeucel® product has been licensed to Cipla in India. Stempeutics is seeking partnership for further clinical development and commercialization of Stempeucel® for Global ...
ByStempeutics Research Pvt. Ltd. based in Bangalore, INDIA